A. Casini Et Al. , "Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia," BLOOD , vol.137, no.22, pp.3127-3136, 2021
Casini, A. Et Al. 2021. Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia. BLOOD , vol.137, no.22 , 3127-3136.
Casini, A., von Mackensen, S., Santoro, C., Khayat, C. D., Belhani, M., Ross, C., ... Dorgalaleh, A.(2021). Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia. BLOOD , vol.137, no.22, 3127-3136.
Casini, Alessandro Et Al. "Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia," BLOOD , vol.137, no.22, 3127-3136, 2021
Casini, Alessandro Et Al. "Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia." BLOOD , vol.137, no.22, pp.3127-3136, 2021
Casini, A. Et Al. (2021) . "Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia." BLOOD , vol.137, no.22, pp.3127-3136.
@article{article, author={Alessandro Casini Et Al. }, title={Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia}, journal={BLOOD}, year=2021, pages={3127-3136} }